New 15-Strain HPV vaccine enters human testing in china
NCT ID NCT06756269
Summary
This study is testing a new HPV vaccine designed to protect against 15 types of the human papillomavirus. It will involve 330 healthy volunteers in China, aged 9 to 45 years old. Researchers will compare the new vaccine to a placebo and an existing vaccine to check how safe it is and how well it triggers an immune response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
RECRUITINGNanning, Guangxi, 530028, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.